Studies Validate bioTheranostics’ Breast Cancer Molecular Test
bioTheranostics reported findings from three studies using the company’s THEROS Breast Cancer Index–a breast cancer molecular test.
Read MorebioTheranostics reported findings from three studies using the company’s THEROS Breast Cancer Index–a breast cancer molecular test.
Read MoreCirculating metastatic breast cancer cells can lose their epithelial receptors, a process that enables them to travel through the bloodstream undetected, according to research from The University of Texas MD Anderson Cancer Center.
Read MoreNew research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death.
Read MoreAdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH and S. aureus/CNS PNA FISH tests.
Read MoreThe Helen F. Graham Cancer Center associated with Christiana Care Health System will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath assay, an early-stage diagnostic test for lung cancer.
Read More